New Horizon Capital Joins Series B Round In Cancer Genomics Start-Up Genetron Health

Login to View

Chinese biotech firm Vcanbio Cell & Gene Engineering Corporation has led a series B round in Genetron Health, a Beijing-based cancer genomics solutions start-up.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

China Money Network Subscription